• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus.

作者信息

Dadzie K Y, Remme J, Alley E S, de Sole G

机构信息

Onchocerciasis Control Programme in West Africa, Ouagadougou, Burkina Faso.

出版信息

Trans R Soc Trop Med Hyg. 1990 Jan-Feb;84(1):103-8. doi: 10.1016/0035-9203(90)90395-u.

DOI:10.1016/0035-9203(90)90395-u
PMID:2345906
Abstract

The impact of ivermectin mass treatment on ocular onchocerciasis was studied in a holoendemic focus of blinding onchocerciasis in Ghana. A cohort of 417 persons, 369 of whom were treated, was followed up at 4 and 12 months after treatment. The mean ocular microfilarial load in the anterior chamber of the eye and in the cornea of treated persons was reduced to less than 20% and 10% of the pretreatment levels respectively at the 4 months follow-up but had increased significantly by 12 months. Lesions of the eye at the advanced stage of development remained stable. There was significant regression of early lesions of the anterior segment of the eye, particularly iridocyclitis, after ivermectin treatment. In view of the substantial increase of ocular microfilarial loads after 12 months, 6-monthly treatment may be indicated in such highly endemic foci. However, long-term observation is needed to give a correct estimate of the full benefit to be derived from mass treatment with ivermectin.

摘要

相似文献

1
Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus.
Trans R Soc Trop Med Hyg. 1990 Jan-Feb;84(1):103-8. doi: 10.1016/0035-9203(90)90395-u.
2
Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.
Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):267-71. doi: 10.1016/0035-9203(91)90051-y.
3
Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone.多次服用伊维菌素对盘尾丝虫性眼病的影响:在塞拉利昂开展的社区试验
Lancet. 1991 Nov 2;338(8775):1100-3. doi: 10.1016/0140-6736(91)91963-u.
4
A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.伊维菌素每6个月、12个月和24个月给药一次治疗盘尾丝虫病的比较。
J Infect Dis. 1991 Feb;163(2):376-80. doi: 10.1093/infdis/163.2.376.
5
Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.一项在治疗盘尾丝虫病中使用安慰剂对照的三剂量伊维菌素比较研究的眼科结果。
Trop Med Parasitol. 1989 Sep;40(3):355-60.
6
Ivermectin treatment of patients with severe ocular onchocerciasis.伊维菌素治疗重度盘尾丝虫性眼病患者
Am J Trop Med Hyg. 1989 May;40(5):494-500. doi: 10.4269/ajtmh.1989.40.494.
7
Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.每半年使用伊维菌素治疗对墨西哥南部盘尾丝虫皮肤感染的患病率和强度、眼部病变以及赭色蚋种群传染性的影响。
Am J Trop Med Hyg. 1995 May;52(5):429-34.
8
The effects of multiple doses of ivermectin on ocular onchocerciasis. A six-year follow-up.
Ophthalmology. 1996 Jul;103(7):1001-8. doi: 10.1016/s0161-6420(96)30574-5.
9
Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin.接受伊维菌素反复治疗的盘尾丝虫病患者的眼部受累情况。
Am J Ophthalmol. 1990 Jul 15;110(1):6-16. doi: 10.1016/s0002-9394(14)76930-2.
10
Ivermectin treatment of ocular onchocerciasis.伊维菌素治疗盘尾丝虫性眼病
Acta Leiden. 1990;59(1-2):201-6.

引用本文的文献

1
Impact of annual dosing with ivermectin on progression of onchocercal visual field loss.伊维菌素年度给药对盘尾丝虫病视野缺损进展的影响。
Bull World Health Organ. 1997;75(3):229-36.
2
Treatment of onchocerciasis.盘尾丝虫病的治疗。
Drugs. 1996 Dec;52(6):861-9. doi: 10.2165/00003495-199652060-00007.
3
Onchocerciasis in Ecuador: evolution of chorioretinopathy after amocarzine treatment.厄瓜多尔的盘尾丝虫病:阿莫卡嗪治疗后脉络膜视网膜炎的演变
Br J Ophthalmol. 1996 Apr;80(4):337-42. doi: 10.1136/bjo.80.4.337.
4
Ivermectin dosing based on physical appearance.
Int Ophthalmol. 1994;18(4):215-9. doi: 10.1007/BF00951800.
5
Points of action in the campaign against blindness in developing countries.发展中国家防治失明运动的行动要点。
Doc Ophthalmol. 1991;78(3-4):285-305. doi: 10.1007/BF00165693.
6
Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.伊维菌素。关于其抗丝虫活性、药代动力学特性及盘尾丝虫病临床疗效的综述。
Drugs. 1991 Oct;42(4):640-58. doi: 10.2165/00003495-199142040-00007.